PFIZER RAISES CORONAVIRUS VACCINE SALES FORECAST TO $33.5B FOR 2021
Thu 29 July 2021: According to a financial results statement released Wednesday, Pfizer raised its revenue forecast for coronavirus vaccine sales to $33.5 billion for 2021. The US pharmaceutical firm’s previous estimates were $26 billion and $15 billion, made in May and February, respectively. The revised projection in revenue from the BNT162b2 vaccine, which was developed with German partner BioNTech, reflects 2.1 billion doses that are expected to be delivered under contracts signed through mid-July, said […]
Continue Reading
